Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apatinib and POF in Advanced Gastric Cancer
NCT03707639Phase 2Unknown
- Sponsor
- Fujian Medical University Cancer Hospital
- Start
- Nov 2018
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Rivoceranib in gastric adenocarcinoma, sponsored by Fujian Medical University Cancer Hospital. Status: unknown.
02
Drugs
Rivoceranib
03
Conditions
gastric adenocarcinoma
Beyond the preview
Go deeper on NCT03707639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03707639.